Jun 162020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MD – Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of David Mott to its Board of Directors as an independent director. Mr. Mott brings more than three decades of global management, board and investment experience across ...

Novavax adds David Mott to its Board as Independent Director

Novavax adds David Mott to its Board as Independent Director

From:: Novavax adds David Mott to its Board as Independent Director

Sorry, the comment form is closed at this time.